ANAB Stock Summary and Trading Ideas (Anaptysbio | NASDAQ:ANAB)

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Anaptysbio trades on the NASDAQ stock market under the symbol ANAB.

As of May 10, 2024, ANAB stock price declined to $23.41 with 320,555 million shares trading.

ANAB has a beta of 0.77, meaning it tends to be less sensitive to market movements. ANAB has a correlation of 0.03 to the broad based SPY ETF.

ANAB has a market cap of $639.53 million. This is considered a Small Cap stock.

Last quarter Anaptysbio reported $7 million in Revenue and -$1.64 earnings per share. This beat revenue expectation by $3 million and missed earnings estimates by -$.08.

In the last 3 years, ANAB stock traded as high as $37.89 and as low as $13.36.

The top ETF exchange traded funds that ANAB belongs to (by Net Assets): XBI, VTI, IWM, VXF, VB.

ANAB has underperformed the market in the last year with a return of +9.0%, while the SPY ETF gained +27.8%. In the last 3 month period, ANAB fell short of the market, returning +1.7%, while SPY returned +4.2%. However, in the most recent 2 weeks ANAB has outperformed the stock market by returning +11.5%, while SPY returned +2.5%.

ANAB support price is $24.86 and resistance is $27.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANAB stock will trade within this expected range on the day.